The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses
- PMID: 18487007
- DOI: 10.1016/j.eururo.2008.04.079
The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses
Abstract
Background: The origin of bilateral renal masses has not been definitively established to date. As limited studies on the genetics of bilateral tumors exist, defining the clinical behavior of these lesions remains important.
Objective: To evaluate the impact of synchronous versus metachronous presentation on clinicopathological outcomes of patients with bilateral renal masses.
Design, setting, and participants: We identified 310 patients who were treated at the Mayo Clinic for sporadic bilateral renal masses between 1970-2003, including 148 (47.7%) with synchronous tumors and 162 (52.3%) with metachronous lesions.
Intervention: Patients underwent surgical resection of bilateral renal tumors.
Measurements: Clinicopathological features of synchronous and metachronous tumors were compared. Survival rates for patients with synchronous (n=92) and metachronous (n=100) renal cell carcinoma (RCC) were estimated using the Kaplan-Meier method and compared with the log rank test.
Results and limitations: Metachronous tumors had a greater degree of pathological concordance than synchronous lesions, with 87.7% of metachronous tumors representing bilateral RCC, compared to 69.2% of synchronous masses (p=0.002). Patients with synchronous RCC tended to have an increased incidence of papillary RCC compared to patients with metachronous RCC, who were more likely to have bilateral clear-cell RCC (p=0.076). A longer interval between tumors was inversely associated with the risk of cancer death for patients with metachronous RCC (HR 0.90, 95% CI 0.81-0.99, p=0.039). Compared to patients with metachronous RCC, patients with synchronous bilateral RCC had similar 10-yr CSS (70.5% vs. 69.4%, p=0.51) and OS (47.5% vs. 51.2%, p=0.58). We nevertheless recognize that these findings may be limited by the study's retrospective, single-institution design.
Conclusions: Metachronous bilateral solid renal masses have a greater degree of pathological concordance and were more likely to represent malignancy. Surgical resection may provide durable cancer control for patients with bilateral RCC, with no difference in survival noted between synchronous and metachronous cancers.
Comment in
-
Editorial comment on: The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.Eur Urol. 2008 Oct;54(4):864. doi: 10.1016/j.eururo.2008.04.080. Epub 2008 May 9. Eur Urol. 2008. PMID: 18487008 No abstract available.
-
Editorial comment on: The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.Eur Urol. 2008 Oct;54(4):864-5. doi: 10.1016/j.eururo.2008.04.081. Epub 2008 May 9. Eur Urol. 2008. PMID: 18487009 No abstract available.
Similar articles
-
The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.J Urol. 2003 Apr;169(4):1276-81. doi: 10.1097/01.ju.0000051883.41237.43. J Urol. 2003. PMID: 12629342
-
Editorial comment on: The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.Eur Urol. 2008 Oct;54(4):864-5. doi: 10.1016/j.eururo.2008.04.081. Epub 2008 May 9. Eur Urol. 2008. PMID: 18487009 No abstract available.
-
Editorial comment on: The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.Eur Urol. 2008 Oct;54(4):864. doi: 10.1016/j.eururo.2008.04.080. Epub 2008 May 9. Eur Urol. 2008. PMID: 18487008 No abstract available.
-
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.Urology. 2004 Sep;64(3):462-7. doi: 10.1016/j.urology.2004.04.016. Urology. 2004. PMID: 15351571 Review.
-
[Synchronous bilateral renal adenocarcinoma. Our experience with conservative kidney surgery].Arch Esp Urol. 1999 Jun;52(5):471-7. Arch Esp Urol. 1999. PMID: 10427885 Review. Spanish.
Cited by
-
Enhancing renal tumors in patients with prior normal abdominal imaging: further insight into the natural history of renal cell carcinoma.J Urol. 2012 Oct;188(4):1089-93. doi: 10.1016/j.juro.2012.06.019. Epub 2012 Aug 15. J Urol. 2012. PMID: 22901590 Free PMC article.
-
Single-cell transcription analysis reveals the tumor origin and heterogeneity of human bilateral renal clear cell carcinoma.Open Life Sci. 2023 Feb 9;18(1):20220569. doi: 10.1515/biol-2022-0569. eCollection 2023. Open Life Sci. 2023. PMID: 36816799 Free PMC article.
-
Synchronous bilateral renal cell carcinomas in "Asynchrony of metabolism".World J Nucl Med. 2019 Jan-Mar;18(1):63-65. doi: 10.4103/wjnm.WJNM_5_18. World J Nucl Med. 2019. PMID: 30774550 Free PMC article.
-
Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.J Urol. 2012 Dec;188(6):2084-8. doi: 10.1016/j.juro.2012.08.038. Epub 2012 Oct 18. J Urol. 2012. PMID: 23083858 Free PMC article.
-
Bilateral synchronous sporadic renal masses: intermediate functional and oncological outcomes at a single institution.Int Urol Nephrol. 2013 Jun;45(3):619-25. doi: 10.1007/s11255-013-0414-2. Epub 2013 Mar 26. Int Urol Nephrol. 2013. PMID: 23529271
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials